Male accessory breast cancer successfully treated with endocrine therapy: A case report

Bi, Lintao; Li, Jun; Shi, Zhangzhen; Zhu, Zhenxing; Lu, Zhenxia

doi:10.3892/ol.2015.3602

Cited by 10 publications

(13 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the Chinese Hospital Knowledge Database from 1975 to 2015, there were two separate case reports of male accessory breast cancer (Gou, 1987;Liu and Wang, 2014), and 20 cases altogether with female patients in the retrospective analyses. Seven case reports in the PubMed literature were in English, of which one case was American (Camisa, 1980), three cases were Chinese (Lin and Wang, 2012;Gao et al, 2014;Bi et al, 2015), and three cases were Japanese (Takeyama et al, 2010;Yamamura et al, 2012;Yoshida et al, 2012). Camisa (1980) reported on an elderly man with accessory breast tissue occurring on the posterior portion of his left thigh.…”

Section: A Brief Literature Review Of Male Accessory Breast Cancermentioning

confidence: 99%

“…Accessory breast carcinoma in males generally presents a poorer prognosis than that in females because the diagnosis tends to be delayed. Bi et al (2015) reported a 56-year-old Chinese male diagnosed with right accessory breast carcinoma (PT1N1M0) who underwent four surgical excisions of a primary ectopic breast carcinoma and developed local lymph node and opposite supraclavicular lymph node metastasis. Ultimately, the patient developed pulmonary and bone metastasis.…”

Section: A Brief Literature Review Of Male Accessory Breast Cancermentioning

confidence: 99%

“…Accessory breasts develop from normal undegraded breasts at an occurrence rate of 2%-6% (Gutermuth et al, 2006). Cancer of accessory breasts is a rare form of breast cancer that usually occurs at an incidence rate of 0.2%-0.6%, usually in the axilla or inguinal region (Bi et al, 2015). Because accessory breast cancer in men, especially the elderly, is extremely rare, missed and erroneous diagnoses often occur, which result in higher instances of metastasis at an early stage and poor prognosis.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Successful treatment of accessory breast cancer with endocrine therapy

Chun-xi

Guo

Han

2017

J. Zhejiang Univ. Sci. B

View full text Add to dashboard Cite

Accessory breast cancers in males are extremely rare, and only a few cases have been reported in the literature. In this paper, an 87-year-old male patient was diagnosed with an accessory breast cancer by means of computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET-CT), and immunohistochemistry based on needle biopsy, and has undergone successful resection and postoperative adjuvant endocrine therapy. He was the oldest male patient with an accessory breast cancer reported in the Chinese Hospital Knowledge Database and PubMed literature from 1975 to 2015.

show abstract

Section: A Brief Literature Review Of Male Accessory Breast Cancermentioning

confidence: 99%

Section: A Brief Literature Review Of Male Accessory Breast Cancermentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Successful treatment of accessory breast cancer with endocrine therapy

Chun-xi

Guo

Han

2017

J. Zhejiang Univ. Sci. B

View full text Add to dashboard Cite

show abstract

“…[ 3 ] Although glandular diseases can also develop in accessory mammary glands, cases of malignant tumors occurring in the accessory mammary glands are extremely rare, especially in male patients. [ 4 ] Therefore, clinicians are short of clinical experience of diagnosis and treatment for male accessory breast cancer, so that the aim of this article is to help clinicians better understand this type of disease.…”

Section: Introductionmentioning

confidence: 99%

Male axillary accessory breast cancer

et al. 2020

Medicine

View full text Add to dashboard Cite

Rationale: Accessory breast cancer is extremely rare among all cancerous diseases, especially in male patients. There were only few male axillary accessory breast cancer cases that have been reported in scientific literatures so far. Hereby, we would like to discuss a case of male axillary accessory breast cancer found in our hospital. Patient concerns: We report a male senile patient suffering from a painful, enlarged, and hardened right axillary mass for more than 20 years. He came for further treatments due to progressive growth of the mass for 11 months with bloody ulceration for more than 1 month. Diagnosis: Pathological examination manifested a grade II infiltrating ductal carcinoma derived from the accessory mammary gland (right axilla), with invasion of local skin. Immunohistochemical examination result: estrogen receptor (++) 90%, progesterone receptor (+++) 100%, human epidermal growth factor receptor-2 (1+), ki67 (20% positive), prostate specific antigen (−), caudal-related homeobox-2 (−), thyroid transcription factor-1 (−), Synaptophysin (+), NapsinA (1), and CK7 (−). Interventions: Modified radical mastectomy and axillary lymph nodes clearance were performed on the accessary breast cancer under general anesthesia. Postoperatively, endocrine therapy was provided for the patient, orally-taken Letrozole was recommended for the rest of the patient's life. Outcomes: The patient recovered uneventfully and was discharged 3 days after the operation. The patient continued to take Letrozole orally regularly at home and no signs of recurrence were observed. Conclusion: Axillary accessory breast cancer in males is extremely rare, with no conspicuous and typical clinical presentations, which leads to inevitable neglect by clinicians. Therefore, there is significant necessity for clinicians to be cautious with this type of disease.

show abstract

“…As noted by Bi et al ., “clinical diagnosis is frequently delayed due to the general lack of awareness among physicians and patients. [ 2 ]” The basic suggestion for any suspected case is to “proceed directly to surgery as their initial diagnostic test. [ 3 ]” Volpe et al .…”

mentioning

confidence: 99%